Advertisement

Topics

FDA approves diagnostic test to differentiate between types of HIV infection

10:57 EDT 23 Jul 2015 | FDA

The U.S. Food and Drug Administration today approved the Bio-Rad BioPlex 2200 HIV Ag-Ab assay, the first FDA-approved diagnostic that differentiates between HIV-1 antibodies, HIV-2 antibodies, and HIV-1 p24 antigen in human serum or plasma specimens.

Original Article: FDA approves diagnostic test to differentiate between types of HIV infection

NEXT ARTICLE

More From BioPortfolio on "FDA approves diagnostic test to differentiate between types of HIV infection"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...